Results 101 to 110 of about 8,840 (216)

The role of optical coherence tomography in the assessment of axonal damage in autoimmune lesions of the optic nerve

open access: yesРоссийский офтальмологический журнал
The purpose of the study was to comparatively analyze optical coherence tomography (OCT) data from patients with neuromyelitis optica (NMOSD) and optic neuritis in multiple sclerosis (MS-ON) to identify structural differences and refine diagnostic ...
A. S.-U. Batchaev   +7 more
doaj   +1 more source

Comparison of clinical features of aquaporin-4 positive neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein associated disorder (MOGAD), and double seronegative NMOSD - A single center experience

open access: yes
This retrospective study investigates Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD), Myelin Oligodendrocyte Glycoprotein Associated Disorder (MOGAD), and Seronegative NMOSD at a tertiary care university hospital, over a 13 ...
ACAR ÖZEN, NAZİRE PINAR   +6 more
core   +1 more source

IL-1β contributes to neurological disability in NMOSD AQP4 + Patients [PDF]

open access: yes
Background Neuromyelitis Optica Spectrum Disorder (NMOSD) is a central nervous system inflammatory disease that causes severe disability. Differently from relapsing-remitting multiple sclerosis (RRMS) a group of patients present aqua-porin-4 (AQP4 ...
Di Lemme S.   +17 more
core   +1 more source

A Study on the Spectrum of Autonomic Dysfunction in Primary Central Nervous System Demyelinating Disorders in a Tertiary Care Center from Eastern India

open access: yesAnnals of Indian Academy of Neurology
Background and Objectives: Primary central nervous system (CNS) demyelinating disorders such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and ...
Debarup Das   +7 more
doaj   +1 more source

A study of referral bias in NMOSD and MOGAD cohorts. [PDF]

open access: yes
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are rare disorders often seen in highly specialized services or tertiary centres.
Sharawakanda, Y   +20 more
core   +1 more source

NMOSD patient anxiety symptoms endorsed on BAI.

open access: yes
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder of the central nervous system with common symptoms of rapid onset of eye pain, loss of vision, neck/back pain, paralysis, bowel and bladder dysfunction and heat sensitivity.
Chelsi N. Nurse (18275708)   +6 more
core   +1 more source

Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review

open access: yesFrontiers in Immunology
ObjectiveThis study aims to delineate the clinical features underlying the concurrent disease of neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (MG), and to identify efficacious therapeutic strategies.BackgroundNMOSD and MG are ...
Xiaoqian Song   +6 more
doaj   +1 more source

NMOSD acute attack: Understanding, treatment and innovative treatment prospect

open access: yes, 2020
Neuromyelitis optica spectrum disorder (NMOSD) is a group of severe inflammatory demyelinating disorders of the central nervous system that involves the optic nerve and spinal cord.
Kermode, A.G., Qiu, W., Hu, X., Ma, X.
core  

Response to treatment in NMOSD: the Australasian experience

open access: yes, 2021
Background: Neuromyelitis optica spectrum disorder (NMOSD) is associated with significant morbidity and mortality. Several therapies have been recommended for NMOSD and more recently clinical trials have demonstrated efficacy for three monoclonal ...
Clarke, L.   +26 more
core  

Cognition and Disability in AQP4-IgG NMOSD

open access: yes
Background/Objectives: Cognitive impairment in neuromyelitis optica spectrum disorder (NMOSD) is increasingly recognized, but its profile and clinical correlates remain uncertain.
Guilherme Diogo Silva   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy